proxyvotesnow.com

Home › Companies › Pulse Biosciences, Inc. › 2025-2026

Pulse Biosciences, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Pulse Biosciences, Inc.’s Form 8-K, filed 2025-12-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 21Reported items
  • 129Asset managers
  • 2,144Fund votes
  • 2025-12-09Main meeting date

Proxy season: 2025-2026

Explore Pulse Biosciences, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Pulse Biosciences, Inc.

These tallies are Pulse Biosciences, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-12-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. Pulse Biosciences, Inc. reported 2 meetings in this season; each is tabulated separately below, with its own filing.

Pulse Biosciences, Inc. — official shareholder meeting results, meeting held 2025-12-09 (Form 8-K, filed 2025-12-12)
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Robert W. Duggan 51,826,4941,329,62733,726 --9,978,532 Majority: yes
Elect Director: Paul A. LaViolette 52,661,322506,48922,036 --9,978,532 Majority: yes
Elect Director: Manmeet S. Soni 52,867,085275,07047,692 --9,978,532 Majority: yes
Elect Director: Darrin R. Uecker 52,633,945527,15928,743 --9,978,532 Majority: yes
Elect Director: Richard A. van den Broek 53,139,40328,31622,128 --9,978,532 Majority: yes
Elect Director: Mahkam Zanganeh, D.D.S. 52,650,407512,83126,609 --9,978,532 Majority: yes
Proposal 2: to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; 63,077,66953,96336,747 ---- Majority: yes
Proposal 3: to approve, by non-binding advisory vote, the compensation of our named executive officers; and 52,270,567907,91611,364 --9,861,834 Majority: yes

Source: Pulse Biosciences, Inc., Form 8-K, filed with the SEC on 2025-12-12 — read the filing on EDGAR.

Pulse Biosciences, Inc. — official shareholder meeting results, meeting held 2026-06-11 (Form 8-K, filed 2026-06-12)
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Robert W. Duggan 33,443,5821,583,174388 --10,974,550 Majority: yes
Elect Director: Paul A. LaViolette 34,264,295759,4013,448 --10,974,550 Majority: yes
Elect Director: Maria Sainz 35,007,10118,3491,694 --10,974,550 Majority: yes
Elect Director: Manmeet S. Soni 33,560,8751,464,5741,695 --10,974,550 Majority: yes
Elect Director: Darrin R. Uecker 34,246,413779,0361,695 --10,974,550 Majority: yes
Elect Director: Richard A. van den Broek 34,278,978746,4711,695 --10,974,550 Majority: yes
Elect Director: Mahkam Zanganeh, D.D.S. 34,241,938783,5111,695 --10,974,550 Majority: yes
Proposal 2: to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; 45,976,3558,26517,074 ---- Majority: yes

Source: Pulse Biosciences, Inc., Form 8-K, filed with the SEC on 2026-06-12 — read the filing on EDGAR.

How asset managers voted at the Pulse Biosciences, Inc. 2025-2026 meetings

Each item below shows how the 129 asset managers that disclosed a Pulse Biosciences, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Pulse Biosciences, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, by non-binding advisory vote, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 52,270,567AGAINST: 907,916

Pulse Biosciences, Inc.’s own tally for this item (“Proposal 3: to approve, by non-binding advisory vote, the compensation of our named executive officers; and”): 52,270,567 for, 907,916 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 77% for, 1% against (78% of the company cast a for/against vote).

The 124 asset managers below cast 64% of the shares they voted on this item FOR (1,506,563 for, 862,862 against).

FOR 64%AGAINST 36%
FOR: 1,506,563 (63.6%)AGAINST: 862,862 (36.4%)
Largest asset managers voting on “To approve, by non-binding advisory vote, the compensation of our named executive officers.” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BANK OF AMERICA NA0771,822 00Against
BlackRock245,5634,283 00For
GRIFFIN ASSET MANAGEMENT, INC.221,0150 00For
Vanguard174,1390 00For
State Street166,7400 00For
Charles Schwab149,8670 00For
Northern Trust90,3370 00For
Fidelity64,3150 00For
GEODE CAPITAL MANAGEMENT, LLC57,0890 00For
Portolan Capital Management, LLC50,9380 00For
Panoramic Capital, LLC37,1980 00For
UBS029,029 00Against
MELLON INVESTMENTS Corp26,5550 00For
Lincoln Financial26,0340 00For
AllianceBernstein20,6200 00For
Equitable20,0680 00For
Northern Lights Fund Trust IV13,0130 00For
OPPENHEIMER & CO INC012,850 00Against
BENDER ROBERT & ASSOCIATES12,6250 00For
Citadel12,4910 00For
FRANKLIN ADVISERS INC12,1190 00For
SEI09,149 00Against
AQR8,2830 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC7,7540 00For
Invesco6,9080 00For

Showing the 25 largest of 124 asset managers. See all 124 in the interactive database.

2. To vote, on an advisory basis, the frequency of future advisory stockholder votes to approve the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-12-09.

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

1 YEAR 62%ONE YEAR 37%

The 121 asset managers below cast 99.9% of the shares they voted on this item FOR (20,226 for, 15 against).

FOR: 20,226 (0.8%)AGAINST: 15 (0.0%)1 YEAR: 1,504,688 (61.8%)ONE YEAR: 898,999 (36.9%)THREE YEARS: 12,491 (0.5%)3 YEARS: 268 (0.0%)
Largest asset managers voting on “To vote, on an advisory basis, the frequency of future advisory stockholder votes to approve the compensation ” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BANK OF AMERICA NA00 001 Year
BlackRock00 001 Year
GRIFFIN ASSET MANAGEMENT, INC.00 00One Year
Vanguard00 00One Year
State Street00 00One Year
Charles Schwab00 001 Year
Northern Lights Fund Trust IV00 001 Year
Northern Trust00 001 Year
Fidelity00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Portolan Capital Management, LLC00 001 Year
UBS00 00One Year
MELLON INVESTMENTS Corp00 00One Year
Lincoln Financial12,1190 00One Year
AllianceBernstein00 00One Year
Equitable00 00One Year
OPPENHEIMER & CO INC00 001 Year
Citadel00 00Three Years
FRANKLIN ADVISERS INC00 00One Year
SEI00 001 Year
AQR00 00One Year
PARAMETRIC PORTFOLIO ASSOCIATES LLC00 00One Year
Invesco00 00One Year
WASHINGTON STATE INVESTMENT BOARD00 001 Year
Rhumbline6,56215 00For

Showing the 25 largest of 121 asset managers. See all 121 in the interactive database.

3. Election of Directors: Darrin R. Uecker

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,246,413AGAINST: 779,036

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Darrin R. Uecker”): 34,246,413 for, 779,036 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 50.5% for, 1% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 95% of the shares they voted on this item FOR (610,857 for, 29,042 against).

FOR 95%
FOR: 610,857 (95.5%)AGAINST: 29,042 (4.5%)
Largest asset managers voting on “Election of Directors: Darrin R. Uecker” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,3660 00For
Fidelity14,7889,879 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR04,112 00Against
AIG/SunAmerica04,101 00Against
Equitable3,7920 00For
John Hancock03,517 00Against
Bridge Builder Trust3,3790 00For
DWS02,469 00Against
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares01,311 00Against
Pacific Life1,2620 00For
Voya01,165 00Against
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley0804 00Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

4. Election of Directors: Mahkam Zanganeh, D.D.S.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,241,938AGAINST: 783,511

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Mahkam Zanganeh, D.D.S.”): 34,241,938 for, 783,511 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 50.5% for, 1% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 95% of the shares they voted on this item FOR (610,857 for, 29,042 against).

FOR 95%
FOR: 610,857 (95.5%)AGAINST: 29,042 (4.5%)
Largest asset managers voting on “Election of Directors: Mahkam Zanganeh, D.D.S.” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,3660 00For
Fidelity14,7889,879 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR04,112 00Against
AIG/SunAmerica04,101 00Against
Equitable3,7920 00For
John Hancock03,517 00Against
Bridge Builder Trust3,3790 00For
DWS02,469 00Against
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares01,311 00Against
Pacific Life1,2620 00For
Voya01,165 00Against
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley0804 00Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

5. Election of Directors: Manmeet S. Soni

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 33,560,875AGAINST: 1,464,574

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Manmeet S. Soni”): 33,560,875 for, 1,464,574 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 49.5% for, 2% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 21% of the shares they voted on this item FOR (132,623 for, 507,277 against).

FOR 21%AGAINST 79%
FOR: 132,623 (20.7%)AGAINST: 507,277 (79.3%)
Largest asset managers voting on “Election of Directors: Manmeet S. Soni” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS0379,056 00Against
BlackRock066,299 00Against
Vanguard57,28879 00For
Fidelity5,54319,124 00Against
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC016,266 00Against
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR04,112 00Against
AIG/SunAmerica04,101 00Against
Equitable03,792 00Against
John Hancock03,517 00Against
Bridge Builder Trust03,379 00Against
DWS02,469 00Against
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares01,311 00Against
Pacific Life01,262 00Against
Voya1,1650 00For
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley0804 00Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

6. Election of Directors: Maria Sainz

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 35,007,101AGAINST: 18,349

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Maria Sainz”): 35,007,101 for, 18,349 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 51.7% for, 0.1% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 99.8% of the shares they voted on this item FOR (639,046 for, 853 against).

FOR 99.8%
FOR: 639,046 (99.9%)AGAINST: 853 (0.1%)
Largest asset managers voting on “Election of Directors: Maria Sainz” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,3660 00For
Fidelity24,6670 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR4,1120 00For
AIG/SunAmerica4,1010 00For
Equitable3,7920 00For
John Hancock3,5170 00For
Bridge Builder Trust3,3790 00For
DWS2,4690 00For
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares1,3110 00For
Pacific Life1,2620 00For
Voya1,1650 00For
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley8040 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

7. Election of Directors: Paul A. LaViolette

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,264,295AGAINST: 759,401

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Paul A. LaViolette”): 34,264,295 for, 759,401 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 50.6% for, 1% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 96% of the shares they voted on this item FOR (611,277 for, 28,622 against).

FOR 96%
FOR: 611,277 (95.5%)AGAINST: 28,622 (4.5%)
Largest asset managers voting on “Election of Directors: Paul A. LaViolette” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,3660 00For
Fidelity14,7889,879 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR04,112 00Against
AIG/SunAmerica04,101 00Against
Equitable3,7920 00For
John Hancock03,517 00Against
Bridge Builder Trust3,3790 00For
DWS02,469 00Against
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares01,311 00Against
Pacific Life1,2620 00For
Voya01,165 00Against
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley0804 00Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

8. Election of Directors: Richard A. van den Broek

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 34,278,978AGAINST: 746,471

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Richard A. van den Broek”): 34,278,978 for, 746,471 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 50.6% for, 1% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 96% of the shares they voted on this item FOR (612,422 for, 27,477 against).

FOR 96%
FOR: 612,422 (95.7%)AGAINST: 27,477 (4.3%)
Largest asset managers voting on “Election of Directors: Richard A. van den Broek” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,3660 00For
Fidelity14,7889,879 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR04,112 00Against
AIG/SunAmerica04,101 00Against
Equitable3,7920 00For
John Hancock03,517 00Against
Bridge Builder Trust3,3790 00For
DWS02,469 00Against
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares01,311 00Against
Pacific Life1,2620 00For
Voya1,1650 00For
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley0804 00Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

9. Election of Directors: Robert W. Duggan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-11.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 33,443,582AGAINST: 1,583,174

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Robert W. Duggan”): 33,443,582 for, 1,583,174 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 49.4% for, 2% against (51.7% of the company cast a for/against vote).

The 37 asset managers below cast 95% of the shares they voted on this item FOR (610,664 for, 29,236 against).

FOR 95%
FOR: 610,664 (95.4%)AGAINST: 29,236 (4.6%)
Largest asset managers voting on “Election of Directors: Robert W. Duggan” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,28879 00For
Fidelity14,7889,879 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR04,112 00Against
AIG/SunAmerica04,101 00Against
Equitable3,7920 00For
John Hancock03,517 00Against
Bridge Builder Trust3,3790 00For
DWS02,469 00Against
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares01,311 00Against
Pacific Life1,2620 00For
Voya01,165 00Against
Strategy Shares1,1570 00For
Calvert0853 00Against
Morgan Stanley0804 00Against

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

10. TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-06-11.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 45,976,355AGAINST: 8,265

Pulse Biosciences, Inc.’s own tally for this item (“Proposal 2: to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026;”): 45,976,355 for, 8,265 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 68% for, 0.1% against (68% of the company cast a for/against vote).

The 37 asset managers below cast 100% of the shares they voted on this item FOR (639,899 for, 0 against).

FOR 100%
FOR: 639,899 (100.0%)
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR TH” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MFS379,0560 00For
BlackRock66,2990 00For
Vanguard57,3660 00For
Fidelity24,6670 00For
Northern Lights Fund Trust IV23,8150 00For
QUANTITATIVE MASTER SERIES LLC16,2660 00For
Charles Schwab14,3110 00For
Lincoln Financial12,1150 00For
Zacks Trust5,9270 00For
SEI4,5000 00For
AQR4,1120 00For
AIG/SunAmerica4,1010 00For
Equitable3,7920 00For
John Hancock3,5170 00For
Bridge Builder Trust3,3790 00For
DWS2,4690 00For
NORTHERN LIGHTS FUND TRUST II2,0330 00For
Global X1,9960 00For
Venerable Variable Insurance Trust1,3320 00For
ProShares1,3110 00For
Pacific Life1,2620 00For
Voya1,1650 00For
Strategy Shares1,1570 00For
Calvert8530 00For
Morgan Stanley8040 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

11. TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-12-09.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 63,077,669AGAINST: 53,963

Pulse Biosciences, Inc.’s own tally for this item (“Proposal 2: to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;”): 63,077,669 for, 53,963 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 93% for, 0.1% against (93% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (463,342 for, 0 against).

FOR 100%
FOR: 463,342 (100.0%)
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR TH” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7220 00For
Charles Schwab74,9330 00For
Fidelity54,1100 00For
Lincoln Financial26,0340 00For
Equitable20,0680 00For
Northern Lights Fund Trust IV13,0130 00For
SEI4,5000 00For
AQR4,1120 00For
Northern Trust4,0230 00For
Global X3,7340 00For
AIG/SunAmerica3,7070 00For
Bridge Builder Trust3,3400 00For
ProShares3,2180 00For
DWS2,7050 00For
Calvert1,8640 00For
Brighthouse1,5450 00For
Venerable Variable Insurance Trust1,4680 00For
Voya1,3440 00For
State Street1,2330 00For
Principal9900 00For
Pacific Life5800 00For
PENN SERIES FUNDS INC5140 00For
Nationwide4810 00For
TIAA4480 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

12. SUBJECT TO APPROVAL OF PROPOSAL 1, TO RATIFY THE GRANT UNDER THE PLAN OF (I) OPTIONS TO ACQUIRE UP TO 500,000 SHARES OF COMMON STOCK GRANTED TO CERTAIN COMPANY CONSULTANTS, AND (II) OPTIONS TO ACQUIRE UP TO 600,000 SHARES OF COMMON STOCK GRANTED TO CERTAIN COMPANY DIRECTORS.

COMPENSATION

Meeting held 2025-09-30; no official results are on file for this meeting.

2% fund support · no official result

AGAINST 98%

The 33 asset managers below cast 2% of the shares they voted on this item FOR (12,996 for, 544,354 against).

FOR: 12,996 (2.3%)AGAINST: 544,354 (97.7%)
Largest asset managers voting on “SUBJECT TO APPROVAL OF PROPOSAL 1, TO RATIFY THE GRANT UNDER THE PLAN OF (I) OPTIONS TO ACQUIRE UP TO 500,000 ” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock0231,699 00Against
Vanguard0153,785 00Against
Fidelity038,749 00Against
Lincoln Financial026,034 00Against
QUANTITATIVE MASTER SERIES LLC021,475 00Against
Charles Schwab019,271 00Against
Equitable015,751 00Against
Northern Lights Fund Trust IV12,9960 00For
AQR08,746 00Against
AIG/SunAmerica05,612 00Against
SEI04,500 00Against
Bridge Builder Trust03,641 00Against
DWS02,705 00Against
Global X02,200 00Against
Voya02,174 00Against
Calvert01,864 00Against
Principal01,649 00Against
State Street01,025 00Against
ProShares01,003 00Against
Pacific Life0657 00Against
PENN SERIES FUNDS INC0514 00Against
TIAA0448 00Against
John Hancock0240 00Against
Nationwide0172 00Against
Guggenheim0162 00Against

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

13. Election of Directors: Robert W. Duggan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 51,826,494AGAINST: 1,329,627

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Robert W. Duggan”): 51,826,494 for, 1,329,627 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 76% for, 2% against (78% of the company cast a for/against vote).

The 32 asset managers below cast 91% of the shares they voted on this item FOR (408,809 for, 38,008 against).

FOR 89%8%
FOR: 408,809 (89.2%)AGAINST: 38,008 (8.3%)ABSTAIN: 11,530 (2.5%)
Largest asset managers voting on “Election of Directors: Robert W. Duggan” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7210 00For
Charles Schwab74,9330 00For
Fidelity45,2898,656 00For
Lincoln Financial13,91512,119 00For
Equitable8,5380 11,5300Abstain
Northern Lights Fund Trust IV13,0130 00For
SEI3,539961 00For
Northern Trust4,0230 00For
Global X3,7340 00For
AIG/SunAmerica03,707 00Against
Bridge Builder Trust3,3400 00For
ProShares03,218 00Against
DWS02,705 00Against
Calvert01,864 00Against
Brighthouse01,545 00Against
Venerable Variable Insurance Trust1,4680 00For
Voya01,322 00Against
State Street1,2240 00For
Principal0990 00Against
Pacific Life5800 00For
Nationwide4810 00For
TIAA0444 00Against
John Hancock0351 00Against
QUANTITATIVE MASTER SERIES LLC1910 00For

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

14. Election of Directors: Darrin R. Uecker

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 3 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 52,633,945AGAINST: 527,159

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Darrin R. Uecker”): 52,633,945 for, 527,159 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 78% for, 0.8% against (78% of the company cast a for/against vote).

The 31 asset managers below cast 92% of the shares they voted on this item FOR (416,817 for, 37,030 against).

FOR 92%8%
FOR: 416,817 (91.8%)AGAINST: 37,030 (8.2%)
Largest asset managers voting on “Election of Directors: Darrin R. Uecker” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7210 00For
Charles Schwab74,9330 00For
Fidelity45,2898,656 00For
Lincoln Financial13,91512,119 00For
Equitable20,0680 00For
Northern Lights Fund Trust IV13,0130 00For
Northern Trust4,0230 00For
Global X3,7340 00For
AIG/SunAmerica03,707 00Against
Bridge Builder Trust3,3400 00For
ProShares03,218 00Against
DWS02,705 00Against
Calvert01,864 00Against
Brighthouse01,545 00Against
Venerable Variable Insurance Trust1,4680 00For
Voya01,322 00Against
State Street1,2240 00For
Principal0990 00Against
Pacific Life5800 00For
Nationwide4810 00For
TIAA0444 00Against
John Hancock0351 00Against
QUANTITATIVE MASTER SERIES LLC1910 00For
Victory Capital087 00Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

15. Election of Directors: Mahkam Zanganeh, D.D.S.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 3 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 52,650,407AGAINST: 512,831

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Mahkam Zanganeh, D.D.S.”): 52,650,407 for, 512,831 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 78% for, 0.8% against (78% of the company cast a for/against vote).

The 31 asset managers below cast 92% of the shares they voted on this item FOR (416,807 for, 37,040 against).

FOR 92%8%
FOR: 416,807 (91.8%)AGAINST: 37,040 (8.2%)
Largest asset managers voting on “Election of Directors: Mahkam Zanganeh, D.D.S.” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7210 00For
Charles Schwab74,9330 00For
Fidelity45,2898,656 00For
Lincoln Financial13,91512,119 00For
Equitable20,0680 00For
Northern Lights Fund Trust IV13,0130 00For
Northern Trust4,0230 00For
Global X3,7340 00For
AIG/SunAmerica03,707 00Against
Bridge Builder Trust3,3400 00For
ProShares03,218 00Against
DWS02,705 00Against
Calvert01,864 00Against
Brighthouse01,545 00Against
Venerable Variable Insurance Trust1,4680 00For
Voya01,322 00Against
State Street1,2240 00For
Principal0990 00Against
Pacific Life5800 00For
Nationwide4810 00For
TIAA0444 00Against
John Hancock0351 00Against
QUANTITATIVE MASTER SERIES LLC1910 00For
Victory Capital087 00Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

16. Election of Directors: Manmeet S. Soni

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 52,867,085AGAINST: 275,070

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Manmeet S. Soni”): 52,867,085 for, 275,070 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 78% for, 0.5% against (78% of the company cast a for/against vote).

The 31 asset managers below cast 95% of the shares they voted on this item FOR (419,646 for, 22,671 against).

FOR 92%
FOR: 419,646 (92.5%)AGAINST: 22,671 (5.0%)ABSTAIN: 11,530 (2.5%)
Largest asset managers voting on “Election of Directors: Manmeet S. Soni” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7210 00For
Charles Schwab74,9330 00For
Fidelity53,9450 00For
Lincoln Financial12,11913,915 00Against
Equitable8,5380 11,5300Abstain
Northern Lights Fund Trust IV13,0130 00For
Northern Trust4,0230 00For
Global X03,734 00Against
AIG/SunAmerica3,7070 00For
Bridge Builder Trust3,3400 00For
ProShares3,2180 00For
DWS2,7050 00For
Calvert01,864 00Against
Brighthouse1,5450 00For
Venerable Variable Insurance Trust01,468 00Against
Voya1,3220 00For
State Street01,224 00Against
Principal9900 00For
Pacific Life5800 00For
Nationwide4810 00For
TIAA0444 00Against
John Hancock3510 00For
QUANTITATIVE MASTER SERIES LLC1910 00For
Victory Capital870 00For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

17. Election of Directors: Paul A. LaViolette

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 3 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 52,661,322AGAINST: 506,489

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Paul A. LaViolette”): 52,661,322 for, 506,489 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 78% for, 0.8% against (78% of the company cast a for/against vote).

The 31 asset managers below cast 92% of the shares they voted on this item FOR (418,139 for, 35,708 against).

FOR 92%8%
FOR: 418,139 (92.1%)AGAINST: 35,708 (7.9%)
Largest asset managers voting on “Election of Directors: Paul A. LaViolette” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7210 00For
Charles Schwab74,9330 00For
Fidelity45,2898,656 00For
Lincoln Financial13,91512,119 00For
Equitable20,0680 00For
Northern Lights Fund Trust IV13,0130 00For
Northern Trust4,0230 00For
Global X3,7340 00For
AIG/SunAmerica03,707 00Against
Bridge Builder Trust3,3400 00For
ProShares03,218 00Against
DWS02,705 00Against
Calvert01,864 00Against
Brighthouse01,545 00Against
Venerable Variable Insurance Trust1,4680 00For
Voya1,3220 00For
State Street1,2240 00For
Principal0990 00Against
Pacific Life5800 00For
Nationwide4810 00For
TIAA0444 00Against
John Hancock0351 00Against
QUANTITATIVE MASTER SERIES LLC1910 00For
Victory Capital087 00Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

18. Election of Directors: Richard A. van den Broek

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-12-09.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 53,139,403AGAINST: 28,316

Pulse Biosciences, Inc.’s own tally for this item (“Elect Director: Richard A. van den Broek”): 53,139,403 for, 28,316 against, per its Form 8-K filed 2025-12-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 67,767,578 outstanding shares: 78% for, 0.1% against (78% of the company cast a for/against vote).

The 31 asset managers below cast 99.5% of the shares they voted on this item FOR (451,983 for, 1,864 against).

FOR 99.5%
FOR: 451,983 (99.6%)AGAINST: 1,864 (0.4%)
Largest asset managers voting on “Election of Directors: Richard A. van den Broek” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard136,6670 00For
BlackRock97,7210 00For
Charles Schwab74,9330 00For
Fidelity53,9450 00For
Lincoln Financial26,0340 00For
Equitable20,0680 00For
Northern Lights Fund Trust IV13,0130 00For
Northern Trust4,0230 00For
Global X3,7340 00For
AIG/SunAmerica3,7070 00For
Bridge Builder Trust3,3400 00For
ProShares3,2180 00For
DWS2,7050 00For
Calvert01,864 00Against
Brighthouse1,5450 00For
Venerable Variable Insurance Trust1,4680 00For
Voya1,3220 00For
State Street1,2240 00For
Principal9900 00For
Pacific Life5800 00For
Nationwide4810 00For
TIAA4440 00For
John Hancock3510 00For
QUANTITATIVE MASTER SERIES LLC1910 00For
Victory Capital870 00For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

19. To approve an amendment to the Pulse Biosciences, Inc. 2017 Equity Incentive Plan (the "Plan"), to increase the number of shares of the Company's common stock issuable under the Plan by 2,000,000 shares and to change the Plan's definition of "Consultant."

COMPENSATION

Meeting held 2025-09-30; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

0% fund support · no official result

AGAINST 100%

The 27 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 287,221 against).

AGAINST: 287,221 (100.0%)
Largest asset managers voting on “To approve an amendment to the Pulse Biosciences, Inc. 2017 Equity Incentive Plan (the "Plan"), to increase th” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard0153,785 00Against
Fidelity038,749 00Against
Lincoln Financial026,034 00Against
Charles Schwab019,271 00Against
Equitable015,751 00Against
AQR08,746 00Against
AIG/SunAmerica05,612 00Against
SEI04,500 00Against
DWS02,705 00Against
Global X02,200 00Against
Voya02,174 00Against
Calvert01,864 00Against
Principal01,649 00Against
State Street01,025 00Against
ProShares01,003 00Against
Pacific Life0657 00Against
PENN SERIES FUNDS INC0514 00Against
TIAA0448 00Against
Nationwide0172 00Against
Guggenheim0162 00Against
Goldman Sachs070 00Against
Invesco066 00Against
E Trade Trust022 00Against
Victory Capital018 00Against
T. Rowe Price017 00Against

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

20. To approve an amendment to the Pulse Biosciences, Inc. 2017 Equity Incentive Plan (the ''Equity Plan''), to increase the number of shares of the Company's common stock issuable under the Plan by 2,000,000 shares and to change the Plan's definition of ''Consultant''.

CAPITAL STRUCTURE

Meeting held 2025-09-30; no official results are on file for this meeting.

5% fund support · no official result

AGAINST 95%

The 5 asset managers below cast 5% of the shares they voted on this item FOR (12,996 for, 257,055 against).

FOR: 12,996 (4.8%)AGAINST: 257,055 (95.2%)
Largest asset managers voting on “To approve an amendment to the Pulse Biosciences, Inc. 2017 Equity Incentive Plan (the ''Equity Plan''), to in” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock0231,699 00Against
QUANTITATIVE MASTER SERIES LLC021,475 00Against
Northern Lights Fund Trust IV12,9960 00For
Bridge Builder Trust03,641 00Against
John Hancock0240 00Against

21. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-12-09.

— fund support · no official result

ONE YEAR 100%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 37,198 (100.0%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Pulse Biosciences, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Panoramic Capital, LLC00 00One Year
Coyle Financial Counsel LLC00 00--

Largest Pulse Biosciences, Inc. shareholders voting in 2025-2026

Ranked by the number of Pulse Biosciences, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 67,767,578 shares outstanding at the time of that meeting.

Top Pulse Biosciences, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1BANK OF AMERICA NA 1.14%
2BlackRock 0.37%
3GRIFFIN ASSET MANAGEMENT, INC. 0.33%
4Vanguard 0.26%
5State Street 0.25%
6Charles Schwab 0.22%
7Northern Trust 0.13%
8Fidelity 0.09%
9GEODE CAPITAL MANAGEMENT, LLC 0.08%
10Portolan Capital Management, LLC 0.08%

Reported Pulse Biosciences, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Pulse Biosciences, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
ROBERT W. DUGGAN 73.35% 13D
BlackRock 1.98% 13F
Vanguard Group 1.65% 13F
Mahkam Zanganeh, D.D.S. 1.29% DEF14A
Geode Capital 0.73% 13F
State Street 0.67% 13F
Manmeet S. Soni 0.66% DEF14A
Darrin R. Uecker 0.42% DEF14A
Richard A. van den Broek 0.39% DEF14A
Northern Trust 0.28% 13F

Percentages above are of 67,767,578 shares outstanding, as reported by Pulse Biosciences, Inc. on its Form 10-Q dated 2025-10-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Pulse Biosciences, Inc.’s 10-Q dated 2025-10-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Pulse Biosciences, Inc.'s 3 shareholder meetings in the 2025-2026 proxy season (held 2025-09-30, 2025-12-09 and 2026-06-11), 129 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,144 separate fund positions. Their filings are grouped here into 21 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2025-12-09 — To approve, by non-binding advisory vote, the compensation of our named executive officers. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Pulse Biosciences, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-12-12.

Pulse Biosciences, Inc. proxy season coverage: 2025-2026 (this page).